nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.26	0.57	CbGbCtD
Ipratropium bromide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0571	0.125	CbGbCtD
Ipratropium bromide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.053	0.116	CbGbCtD
Ipratropium bromide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0244	0.0534	CbGbCtD
Ipratropium bromide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0239	0.0525	CbGbCtD
Ipratropium bromide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0223	0.0489	CbGbCtD
Ipratropium bromide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0152	0.0334	CbGbCtD
Ipratropium bromide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.000854	CcSEcCtD
Ipratropium bromide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.000854	CcSEcCtD
Ipratropium bromide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000463	0.000851	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000463	0.000851	CcSEcCtD
Ipratropium bromide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000463	0.000851	CcSEcCtD
Ipratropium bromide—Infection—Cisplatin—peripheral nervous system neoplasm	0.00046	0.000845	CcSEcCtD
Ipratropium bromide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000459	0.000844	CcSEcCtD
Ipratropium bromide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000456	0.000838	CcSEcCtD
Ipratropium bromide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000456	0.000838	CcSEcCtD
Ipratropium bromide—Rash—Topotecan—peripheral nervous system neoplasm	0.000455	0.000837	CcSEcCtD
Ipratropium bromide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000455	0.000836	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000454	0.000834	CcSEcCtD
Ipratropium bromide—Cough—Etoposide—peripheral nervous system neoplasm	0.000453	0.000833	CcSEcCtD
Ipratropium bromide—Headache—Topotecan—peripheral nervous system neoplasm	0.000452	0.000832	CcSEcCtD
Ipratropium bromide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000452	0.000831	CcSEcCtD
Ipratropium bromide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000452	0.000831	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000452	0.00083	CcSEcCtD
Ipratropium bromide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000451	0.00083	CcSEcCtD
Ipratropium bromide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000451	0.00083	CcSEcCtD
Ipratropium bromide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000451	0.00083	CcSEcCtD
Ipratropium bromide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000451	0.000829	CcSEcCtD
Ipratropium bromide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00045	0.000827	CcSEcCtD
Ipratropium bromide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000449	0.000826	CcSEcCtD
Ipratropium bromide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000449	0.000825	CcSEcCtD
Ipratropium bromide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000449	0.000825	CcSEcCtD
Ipratropium bromide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000448	0.000824	CcSEcCtD
Ipratropium bromide—Pain—Vincristine—peripheral nervous system neoplasm	0.000447	0.000823	CcSEcCtD
Ipratropium bromide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000447	0.000823	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000447	0.000822	CcSEcCtD
Ipratropium bromide—Rash—Melphalan—peripheral nervous system neoplasm	0.000446	0.00082	CcSEcCtD
Ipratropium bromide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000445	0.000819	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000444	0.000816	CcSEcCtD
Ipratropium bromide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000442	0.000813	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000439	0.000807	CcSEcCtD
Ipratropium bromide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000432	0.000795	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000431	0.000793	CcSEcCtD
Ipratropium bromide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000431	0.000793	CcSEcCtD
Ipratropium bromide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.000789	CcSEcCtD
Ipratropium bromide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000429	0.000789	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000428	0.000787	CcSEcCtD
Ipratropium bromide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000426	0.000782	CcSEcCtD
Ipratropium bromide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000426	0.000782	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000424	0.000779	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000421	0.000775	CcSEcCtD
Ipratropium bromide—Infection—Etoposide—peripheral nervous system neoplasm	0.000421	0.000774	CcSEcCtD
Ipratropium bromide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00042	0.000772	CcSEcCtD
Ipratropium bromide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00042	0.000772	CcSEcCtD
Ipratropium bromide—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000768	CcSEcCtD
Ipratropium bromide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000768	CcSEcCtD
Ipratropium bromide—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000768	CcSEcCtD
Ipratropium bromide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000415	0.000764	CcSEcCtD
Ipratropium bromide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000414	0.000761	CcSEcCtD
Ipratropium bromide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000414	0.00076	CcSEcCtD
Ipratropium bromide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000412	0.000758	CcSEcCtD
Ipratropium bromide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000412	0.000757	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00041	0.000753	CcSEcCtD
Ipratropium bromide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000739	CcSEcCtD
Ipratropium bromide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000401	0.000737	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0004	0.000735	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000399	0.000734	CcSEcCtD
Ipratropium bromide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000396	0.000728	CcSEcCtD
Ipratropium bromide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000396	0.000727	CcSEcCtD
Ipratropium bromide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000718	CcSEcCtD
Ipratropium bromide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.000716	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000714	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000711	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000711	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000711	CcSEcCtD
Ipratropium bromide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000386	0.00071	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000385	0.000709	CcSEcCtD
Ipratropium bromide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.000706	CcSEcCtD
Ipratropium bromide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000381	0.0007	CcSEcCtD
Ipratropium bromide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000378	0.000695	CcSEcCtD
Ipratropium bromide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000377	0.000693	CcSEcCtD
Ipratropium bromide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000375	0.00069	CcSEcCtD
Ipratropium bromide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000372	0.000685	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000683	CcSEcCtD
Ipratropium bromide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.000683	CcSEcCtD
Ipratropium bromide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000369	0.000679	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000366	0.000673	CcSEcCtD
Ipratropium bromide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000365	0.000672	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000671	CcSEcCtD
Ipratropium bromide—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000668	CcSEcCtD
Ipratropium bromide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000362	0.000666	CcSEcCtD
Ipratropium bromide—Pain—Etoposide—peripheral nervous system neoplasm	0.000362	0.000666	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000666	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000666	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000665	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000661	CcSEcCtD
Ipratropium bromide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.00066	CcSEcCtD
Ipratropium bromide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000358	0.000658	CcSEcCtD
Ipratropium bromide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000657	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000657	CcSEcCtD
Ipratropium bromide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000646	CcSEcCtD
Ipratropium bromide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000643	CcSEcCtD
Ipratropium bromide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000348	0.00064	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000347	0.000637	CcSEcCtD
Ipratropium bromide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000346	0.000636	CcSEcCtD
Ipratropium bromide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000345	0.000635	CcSEcCtD
Ipratropium bromide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.000629	CcSEcCtD
Ipratropium bromide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.000629	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000341	0.000627	CcSEcCtD
Ipratropium bromide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.000625	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000621	CcSEcCtD
Ipratropium bromide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000337	0.000619	CcSEcCtD
Ipratropium bromide—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000618	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000618	CcSEcCtD
Ipratropium bromide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000616	CcSEcCtD
Ipratropium bromide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000335	0.000616	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000616	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000616	CcSEcCtD
Ipratropium bromide—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000615	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000612	CcSEcCtD
Ipratropium bromide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000333	0.000612	CcSEcCtD
Ipratropium bromide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000332	0.00061	CcSEcCtD
Ipratropium bromide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000332	0.00061	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000608	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000607	CcSEcCtD
Ipratropium bromide—Rash—Vincristine—peripheral nervous system neoplasm	0.00033	0.000607	CcSEcCtD
Ipratropium bromide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00033	0.000606	CcSEcCtD
Ipratropium bromide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000603	CcSEcCtD
Ipratropium bromide—Headache—Vincristine—peripheral nervous system neoplasm	0.000328	0.000603	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000598	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000595	CcSEcCtD
Ipratropium bromide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.000593	CcSEcCtD
Ipratropium bromide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000592	CcSEcCtD
Ipratropium bromide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000317	0.000582	CcSEcCtD
Ipratropium bromide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000575	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000312	0.000574	CcSEcCtD
Ipratropium bromide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000573	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000572	CcSEcCtD
Ipratropium bromide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000311	0.000571	CcSEcCtD
Ipratropium bromide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000571	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000571	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00057	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000569	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000566	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000565	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000562	CcSEcCtD
Ipratropium bromide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000304	0.000559	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000558	CcSEcCtD
Ipratropium bromide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000555	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000554	CcSEcCtD
Ipratropium bromide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.0003	0.000551	CcSEcCtD
Ipratropium bromide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000548	CcSEcCtD
Ipratropium bromide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000294	0.000541	CcSEcCtD
Ipratropium bromide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000292	0.000536	CcSEcCtD
Ipratropium bromide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000291	0.000536	CcSEcCtD
Ipratropium bromide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00029	0.000533	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000532	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.00053	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000528	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000528	CcSEcCtD
Ipratropium bromide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000527	CcSEcCtD
Ipratropium bromide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000525	CcSEcCtD
Ipratropium bromide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000524	CcSEcCtD
Ipratropium bromide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000283	0.00052	CcSEcCtD
Ipratropium bromide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000518	CcSEcCtD
Ipratropium bromide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00028	0.000515	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000514	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000513	CcSEcCtD
Ipratropium bromide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000275	0.000505	CcSEcCtD
Ipratropium bromide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000504	CcSEcCtD
Ipratropium bromide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000269	0.000495	CcSEcCtD
Ipratropium bromide—Rash—Etoposide—peripheral nervous system neoplasm	0.000267	0.000491	CcSEcCtD
Ipratropium bromide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000267	0.000491	CcSEcCtD
Ipratropium bromide—Headache—Etoposide—peripheral nervous system neoplasm	0.000266	0.000488	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000488	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000486	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000485	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000481	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000479	CcSEcCtD
Ipratropium bromide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000473	CcSEcCtD
Ipratropium bromide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000467	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000467	CcSEcCtD
Ipratropium bromide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000252	0.000463	CcSEcCtD
Ipratropium bromide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000462	CcSEcCtD
Ipratropium bromide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000456	CcSEcCtD
Ipratropium bromide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000456	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000453	CcSEcCtD
Ipratropium bromide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000446	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000438	CcSEcCtD
Ipratropium bromide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000437	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000437	CcSEcCtD
Ipratropium bromide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000434	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000432	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000428	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000428	CcSEcCtD
Ipratropium bromide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000426	CcSEcCtD
Ipratropium bromide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000424	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000422	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000422	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000422	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000419	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000412	CcSEcCtD
Ipratropium bromide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000408	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000404	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000404	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000402	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000398	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000396	CcSEcCtD
Ipratropium bromide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000395	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000394	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000393	CcSEcCtD
Ipratropium bromide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000392	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000391	CcSEcCtD
Ipratropium bromide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000389	CcSEcCtD
Ipratropium bromide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000388	CcSEcCtD
Ipratropium bromide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000384	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000378	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000377	CcSEcCtD
Ipratropium bromide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000377	CcSEcCtD
Ipratropium bromide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000374	CcSEcCtD
Ipratropium bromide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000374	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000368	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000366	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000363	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00036	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000359	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000357	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000356	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000349	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000348	CcSEcCtD
Ipratropium bromide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000347	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000346	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000346	CcSEcCtD
Ipratropium bromide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000345	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00033	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000322	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000321	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000319	CcSEcCtD
Ipratropium bromide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000313	CcSEcCtD
Ipratropium bromide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000309	CcSEcCtD
Ipratropium bromide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000299	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000298	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00029	CcSEcCtD
Ipratropium bromide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000289	CcSEcCtD
Ipratropium bromide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000286	CcSEcCtD
Ipratropium bromide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000278	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000277	CcSEcCtD
Ipratropium bromide—Rash—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000275	CcSEcCtD
Ipratropium bromide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000275	CcSEcCtD
Ipratropium bromide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000274	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000267	CcSEcCtD
Ipratropium bromide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000259	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000257	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000255	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000255	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000253	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00024	CcSEcCtD
